| Название продукта | Эмпаглифлозин |
|---|---|
| Номер CAS | 864070-44-0 |
| Молекулярная формула | C23H27ClO7 |
| Молекулярная масса | 450.91 |
| Внешний вид | Кристаллический порошок от белого до небелого цвета |
| Анализ (ВЭЖХ) | ≥98% |
| Потери при сушке | ≤0,51 TP3T |
| Остаток после прокаливания | ≤0,11 TP3T |
| Тяжелые металлы | ≤10 ppm |
| Температура плавления | 152-156°C |
| Удельное вращение | -10° to -15° (c=1, methanol) |
Нужна помощь? Свяжитесь с нашей командой

Синонимы
Empagliflozin, Jardiance, BI-10773, 1-Chloro-4-(β-D-glucopyranos-1-yl)-2-[4-((S)-tetrahydrofuran-3-yloxy)-benzyl]-benzene
Empagliflozin has quietly become one of the most prescribed SGLT2 inhibitors in the world, and it’s not hard to see why. Unlike older diabetes drugs that just push insulin harder, empagliflozin works by telling the kidneys to let go of excess glucose — literally flushing it out through urine. That mechanism not only lowers blood sugar but also delivers a nice side effect: many patients see modest weight loss and a reduction in cardiovascular risk. For a diabetic patient, that’s a triple win.
For manufacturers, empagliflozin is a workhorse API. It’s the active ingredient in Jardiance, which has been shown to reduce cardiovascular death in type 2 diabetes patients — a claim not many oral antidiabetics can make. We supply empagliflozin as a high-purity crystalline powder, with every batch tested to meet strict spec limits. Whether you need 1 kg for R&D or a full drum for production, we’ve got you covered, and our lead times are short enough to keep your line moving.